Endo-Vascular Investigation Determining the Safety of a New Tacrolimus Eluting Stent Graft - EVIDENT
Evaluation of a tacrolimus-eluting stent graft designed for diseased saphenous vein bypass grafts.
Patients Enrolled: 15
Death, MI, TVR
15 patients received the stent graft coated with 322 mcg tacrolimus.
No events have been observed.
Results are pending.
Keywords: Coronary Artery Disease, Drug-Eluting Stents, Saphenous Vein, Tacrolimus
< Back to Listings